Dr. Mohamad Asmi, MD
A Senior Interventional Cardiologist with more than three decades of hands-on experience in high-volume catheterization laboratories across the Middle East and Europe. He has personally performed over 20,000 coronary angiographies and 6,000+ PCI procedures, with extensive expertise in pacemaker systems, invasive hemodynamics, and advanced cardiac imaging. He advises medical device and cath-lab technology companies on clinical validation, workflow integration, physician adoption, and product positioning. His background includes leadership roles as hospital CEO and medical director, giving him practical insight into procurement decisions, technology assessment, and real-world clinical deployment. Dr. Asmi supports device manufacturers in areas including interventional platforms, imaging and echo technologies, cath-lab equipment, and AI-enabled cardiology solutions, bridging clinical performance with operational and market realities.
Dr. Khaled Ahmed Naji Al-Mudaliji
A Consultant general surgeon with over 25 years of experience across Syria and Saudi Arabia, specializing in advanced wound care and diabetic foot management. Holds an MD from Damascus University, board certification in General Surgery, and advanced wound care certification from Canada (IIWCC, Toronto). Actively supports medical device companies through clinical insight, product evaluation, physician training, and alignment of wound-care technologies with practical clinical requirements.
Dr. Anas Makhzoum, MD, FRCPC, DABIM
A Canadian board-certified Rheumatologist and Internist with extensive experience supporting pharmaceutical and medical-technology initiatives. He advises on product positioning, clinical relevance, and medical validation, with hands-on involvement in Phase III clinical trials and biologic therapies. His expertise includes medical affairs, clinical strategy, product evaluation, and professional medical education. Dr. Makhzoum combines frontline clinical practice with academic and research experience, providing practical, evidence-based guidance for healthcare companies.